Optiviral Eye Ointment contains Acyclovir 3% w/w, an antiviral agent indicated for the treatment of herpetic keratitis and other ocular infections caused by herpes simplex virus. Acyclovir acts by inhibiting viral DNA polymerase, thereby preventing viral replication and reducing the severity and duration of the infection. This ointment is formulated for topical ophthalmic use, providing targeted delivery to the affected area while minimizing systemic absorption. Optiviral Eye Ointment is typically administered five times daily at regular intervals, including during the night, for a duration prescribed by the healthcare professional, usually ranging from 7 to 14 days depending on the clinical response. Patients should be advised to avoid contamination of the applicator tip and to wash hands before and after application to prevent the spread of infection. Common adverse effects may include mild ocular irritation, burning sensation, or transient blurred vision. Caution is advised in patients with known hypersensitivity to acyclovir or any component of the formulation. This product should be stored at controlled room temperature, protected from light and moisture. Optiviral Eye Ointment is a critical therapeutic option for managing herpetic eye infections, promoting healing and preventing complications such as corneal scarring and vision loss.